Retrospective Study Assessing Outcomes of AYA Patients with Lymphoma Following Auto Stem Cell Transplant
Hematopoietic stem cell transplantation (HSCT) offers a potential curative option and can prolong overall survival (OS) for many patients with Hodgkin and non-Hodgkin Lymphomas (NHL). Lymphomas in the adolescent and young adult (AYA) population have had minimal improvement in lymphoma-specific survival rates over the years, especially when compared to pediatric and older populations. AYAs also are at increased risk for treatment/disease related late effects given the likelihood of longer life spans following treatment.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Daniel Charles Stapor, Yuliya Shestovska, Rashmi Khanal, Peter Abdelmessieh, Michael J Styler, Henry Fung, Asya Varshavsky Yanovsky Tags: 498 Source Type: research
More News: Biology | Hematology | Hodgkin's Disease | Lymphoma | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Transplants